文献速递创伤骨科关节外科

髋部股骨假体周围骨折的处理与结局:来自假体周围骨折服务评估的特征、结局与管理(COMPOSE)队列研究数据

Management and outcomes of femoral periprosthetic fractures at the hip : data from the characteristics, outcomes and management of periprosthetic fracture service evaluation (COMPOSE) cohort study.
PubMed 文献 · Bone Joint J · 2022-01-01

这项多中心回顾性队列研究纳入英国27家NHS医院2018年全年539例新发髋部股骨假体周围骨折成人患者,417例(77%)手术、122例(23%)保守治疗,手术距入院中位4天;12个月再手术率5.6%、30天再入院率8.4%、30天和12个月死亡率分别为5.2%和21.0%,保守治疗、高龄、男性、来自养老机构及翻修假体周围骨折是12个月死亡率升高的显著预测因素。

要点

  • 417例(77%)手术、122例(23%)保守治疗,手术距入院中位4天(IQR 2–7)。
  • B2/B3型翻修率最高(均77%),B1型(71%)和C型(75%)单纯固定率最高。
  • 12个月再手术率5.6%、30天再入院率8.4%、30天和12个月死亡率5.2%和21.0%。

核心结论

  • 髋部股骨假体周围骨折的死亡率、再手术率和再入院率与髋部骨折患者相当,但手术等待时间更长、手术治疗更复杂。
  • 作者认为需要建立国家层面的数据收集框架,以了解这一异质性患者群体不同治疗方式的结局。

研究设计与样本

  • 多中心回顾性队列研究,纳入2018年1月1日至2018年12月31日期间就诊于27家NHS医院的成人新发髋部股骨假体周围骨折患者,共539例。
  • 收集管理策略(手术与非手术)、住院时间、出院去向及治疗后结局(再手术、再入院、30天和12个月死亡率),按骨折类型进行描述性分析,并使用混合效应逻辑回归评估管理及结局的预测因素。

主要发现

  • 417例(77%)手术治疗,122例(23%)保守治疗;手术患者中246例(59%)行翻修和/或固定,169例(41%)仅行固定。
  • 手术策略因统一分类系统(UCS)骨折类型而异:B2型翻修率77%(176/228)、B3型翻修率77%(24/31);B1型单纯固定率71%(55/78)、C型单纯固定率75%(49/65)。
  • 骨水泥柄固定(OR 2.66,95%CI 1.42–4.99;p=0.002)和B2/B3型骨折(OR 7.56,95%CI 4.14–13.78;p<0.001)是手术管理的预测因素。
  • 住院时间中位15天(IQR 9–23),12个月再手术率5.6%(n=30),30天再入院率8.4%(n=45),30天死亡率5.2%(n=28),12个月死亡率21.0%(n=113)。
  • 保守治疗、高龄、男性、来自养老或护理机构、翻修假体周围骨折是12个月死亡率升高的显著预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to describe the management and associated outcomes of patients sustaining a femoral hip periprosthetic fracture (PPF) in the UK population. METHODS: This was a multicentre retrospective cohort study including adult patients who presented to 27 NHS hospitals with 539 new PPFs between 1 January 2018 and 31 December 2018. Data collected included: management strategy (operative and nonoperative), length of stay, discharge destination, and details of post-treatment outcomes (reoperation, readmission, and 30-day and 12-month mortality). Descriptive analysis by fracture type was performed, and predictors of PPF management and outcomes were assessed using mixed-effects logistic regression. RESULTS: In all, 417 fractures (77%) were managed operatively and 122 (23%) conservatively. The median time to surgery was four days (interquartile range (IQR) 2 to 7). Of those undergoing surgery, 246 (59%) underwent revision and/or fixation and 169 (41%) fixation alone. The surgical strategy used differed by Unified Classification System for PPF type, with the highest rate of revision in B2/B3 fractures (both 77%, 176/228 and 24/31, respectively) and the highest rate of fixation alone in B1- (55/78; 71%) and C-type (49/65; 75%) fractures. Cemented stem fixation (odds ratio (OR) 2.66 (95% confidence interval (CI) 1.42 to 4.99); p = 0.002) and B2/B3 fracture type (OR 7.56 (95% CI 4.14 to 13.78); p < 0.001) were predictors of operative management. The median length of stay was 15 days (IQR 9 to 23), 12-month reoperation rate was 5.6% (n = 30), and 30-day readmission rate was 8.4% (n = 45). The 30-day and 12-month mortality rates were 5.2% (n = 28) and 21.0% (n = 113). Nonoperative treatment, older age, male sex, admission from residential or nursing care, and sustaining the PPF around a revision prosthesis were significant predictors of an increased 12-month mortality. CONCLUSION: Femoral hip PPFs have mortality, reoperation, and readmission rates comparable with hip fracture patients. However, they have a longer wait for surgery, and surgical treatment is more complex. There is a need to create a national framework for data collection for this heterogeneous group of patients in order to understand the outcomes of different approaches to treatment. Cite this article: Bone Joint J 2022;104-B(8):997-1008 .

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Management and outcomes of femoral periprosthetic fractures at the hip : data from the characteristics, outcomes and management of periprosthetic fracture service evaluation (COMPOSE) cohort study. Bone Joint J. 2022. PMID: 35909379. doi:10.1302/0301-620X.104B8.BJJ-2021-1682.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。